This webinar will focus on the identification and management of alcohol withdrawal in the emergency department (ED) and the critical role ED clinicians play in initiating treatment for alcohol use disorder (AUD). The session will review patient selection criteria, dosing considerations, and administration techniques for medications such as naltrexone, acamprosate, and gabapentin, as well as additional treatment options including disulfiram and topiramate. Attendees will also explore strategies for addressing co-occurring behavioral health concerns and collaborating with interdisciplinary team members to connect patients with appropriate follow-up treatment and recovery resources.

This webinar will explore the epidemiology and clinical presentation of alcohol withdrawal syndrome (AWS), with a focus on identifying patients at risk for developing withdrawal symptoms and related complications. Participants will gain an understanding of the neurobiology of alcohol withdrawal and the underlying mechanisms that contribute to symptom development. The session will also review the Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar) tool and its role in assessing withdrawal severity. Learners will be equipped with practical strategies to evaluate patients and make informed decisions regarding the safe and effective management of AWS in outpatient settings.

This case-based discussion will explore the complex relationship between chronic pain and alcohol use disorder (AUD), highlighting how these conditions can interact and reinforce one another through factors such as analgesia, withdrawal, sleep disruption, negative affect, and functional impairment. Through the review of a clinical case, participants will examine key assessment considerations, including pain interference and liver health, while discussing practical strategies for identifying risks and treatment needs. The session will also focus on evidence-informed, integrated approaches to care that combine medications for AUD and psychosocial interventions to support safer and more effective outcomes for individuals experiencing both chronic pain and alcohol use disorder.

This case-based discussion will provide an overview of evidence-supported therapeutic approaches, including motivational interviewing, cognitive-behavioral therapy, contingency management, trauma-informed interventions, and Acceptance and Commitment Therapy (ACT). Participants will explore how experiential avoidance can contribute to ongoing alcohol-related challenges and consider strategies for enhancing motivation, engagement, and behavior change. The session will also examine the complementary roles of medications for alcohol use disorder (MAUD) and psychotherapy in supporting recovery goals.

This webinar will explore the emerging role of neuromodulation in the treatment of alcohol use disorder (AUD), highlighting how advances in neuroscience are creating new opportunities to address the brain circuits involved in addiction. Participants will examine the neurobiological foundations of substance use disorders and learn how neuromodulation techniques, including transcranial magnetic stimulation (TMS) and focused ultrasound, have evolved as treatment modalities with growing applications across a range of conditions. The session will also review current research on the use of these technologies in AUD and discuss their potential integration with other therapeutic approaches to enhance treatment outcomes and support long-term recovery.

This webinar will examine how telemedicine can help address the treatment gap for alcohol use disorder (AUD). Participants will learn how telehealth can expand access to medications for alcohol use disorder (MAUD), particularly for patients in rural areas and communities where transportation challenges and geographic distance can limit access to care. Using real-world patient cases, the presenter will discuss which individuals are best suited for telemedicine-based treatment, how virtual care can enhance patient engagement and continuity of care, and practical strategies for integrating telemedicine and MAUD into everyday clinical practice.

This case-based discussion will explore the complex, bidirectional relationship between sleep and alcohol use, highlighting how sleep problems can contribute to alcohol misuse and recovery challenges. Participants will examine the prevalence and impact of insomnia and other sleep disturbances in AUD, review the evidence supporting cognitive behavioral and pharmacological treatment approaches, and discuss practical strategies for addressing co-occurring sleep and alcohol-related concerns. By the end of the session, attendees will be better equipped to recognize sleep-related issues in this population and identify effective treatment options to support recovery and overall well-being.

This webinar will review common and serious medical comorbidities associated with AUD and discuss their implications for treatment planning. Participants will learn how to safely and effectively modify medications for Alcohol Use Disorder (MAUD) in the presence of medical comorbidities, while also exploring the potential impact of these medications on overall health outcomes.

This webinar will explore how alcohol disrupts blood cell production and function, including bone marrow toxicity, impaired nutrient absorption, increased bleeding risk, and increased vulnerability to infection. Because clinicians frequently encounter these hematologic abnormalities without a clear underlying cause, understanding alcohol's role can improve diagnosis, inform treatment decisions, and support more effective patient management. Participants will learn how alcohol affects blood cells and platelets, recognize common hematologic complications associated with alcohol use, and apply these insights to enhance clinical assessment and care.

This webinar will explore the pharmacology of GLP-1 medications and examine the growing body of research investigating their impact on alcohol cravings and recovery outcomes. Participants will review emerging evidence supporting the use of GLP-1s for alcohol use disorder, while also considering important clinical questions, limitations, and concerns surrounding their use in this evolving area of addiction treatment.

This case-based discussion will equip attendees with practical strategies to better understand, identify, and address stigma related to medications for alcohol use disorder (MAUD) while exploring diverse recovery pathways that incorporate a range of evidence-based treatments. Through real-world case discussions, participants will examine how stigma—both internalized and external—shapes treatment engagement, decision-making, and recovery environments, particularly within peer recovery communities, and will learn how to build more comprehensive systems of care. Attendees will also gain insight into the role of MAUD in treating alcohol use disorder, understand how stigma manifests across settings, and develop practical strategies to support inclusive, all-encompassing recovery pathways.

In this webinar, attendees will learn how organizations can successfully integrate MAUD and AUD treatment into the Certified Community Behavioral Health Clinic (CCBHC) service model. This session will highlight lessons learned from organizational change and clinical integration at Integrity House, a CCBHC in New Jersey. Through this real-world example, attendees will explore approaches to strengthening care coordination, increasing treatment engagement and addressing common implementation hurdles across multidisciplinary teams, equipping them with practical strategies to expand access to care and improve outcomes.

This webinar will examine the clinical implications of alcohol use disorder (AUD) among patients receiving care in opioid treatment programs (OTPs) and office-based opioid use disorder treatment (OBOT) settings. Participants will learn about the epidemiology of AUD in individuals with opioid use disorder (OUD) and the impact of this co-occurrence on patient outcomes. The session will also review best practices for screening, diagnosis, and biochemical testing for AUD in patients receiving medications for opioid use disorder (MOUD). Finally, the webinar will provide practical, evidence-based strategies for integrating medications for alcohol use disorder (MAUD) into OTP and OBOT settings to support comprehensive, patient-centered care.

This case-based discussion will focus on the identification and management of alcohol use disorder in primary care settings. Using real-world clinical scenarios, participants will explore evidence-based screening and diagnostic strategies, determine appropriate levels of care and referral using the ASAM Criteria, and learn how to initiate and manage medication treatment for alcohol use disorder. The session also emphasizes practical approaches to supporting patient engagement, addressing ambivalence, and maintaining strong care coordination.

This case-based discussion will explore gambling disorder as a behavioral addiction, with a particular focus on its prevalence and frequent comorbidity with alcohol use disorder. Through guided discussion, learners will examine how gambling and alcohol cravings present in real-world settings, identify evidence-based psychotherapeutic treatments for gambling disorder, and review validated screening and assessment tools, and discuss potential coping options for gambling and alcohol use triggers. 

In this case based discussion, participants will learn practical strategies for engaging patients who feel uncertain or ambivalent about change, using motivational interviewing (MI) techniques to support autonomy and assess readiness to change. By applying the MI OARS framework, participants will gain tools to guide focused, goal-oriented conversations that encourage positive behavior change and increase readiness to accept behavioral and/or medical treatment referrals.

This webinar features a panel discussion on the complex intersection of alcohol use disorder (AUD) and liver transplantation. This conversation will explore the medical, ethical, and social challenges faced by healthcare professionals, patients, and policy makers in determining eligibility, managing post-transplant care, and addressing the stigma surrounding these issues. 

This session will highlight the many ways families influence a loved one’s recovery journey, including how stigma, family culture, and boundaries can help or hinder progress. Participants will learn how to assess family dynamics, offer clear and appropriate education about AUD treatment options, and connect families with supportive resources such as Family Resource Centers, Recovery Community Organizations, and mutual aid groups.

Alcoholics Anonymous and SMART Recovery represent two of the best forms of group treatment for alcohol use disorder. In addition to medications for alcohol use disorder, being knowledgeable about these programs is essential in order to provide best care to patients. Join us for a one hour webinar led by Dr. Brian Fuehrlein, MD, PhD, Associate Professor Psychiatry at Yale University, as he provides an overview on these programs, how they work, and who will benefit from them.

This live webinar will discuss best practices and approaches for screening and evaluating patient alcohol use and readiness to change in the outpatient and urgent care settings. It will emphasize the need of interprofessional participation in alcohol use screening and will present models and implementation strategies for healthcare professionals to consider.

This webinar will explore the underutilization of MAUD in residential treatment settings and how residential treatment programs can integrate MAUD into their care models to reduce recurrence of use, encourage treatment retention and support better health outcomes. Attendees will learn from a respected addiction psychotherapist with expertise in integrated behavioral health before diving into a brief discussion utilizing case examples.

This case-based discussion will discuss the four key motivators behind alcohol use and explore practical, compassionate, and evidence-based strategies for supporting individuals in environments where drinking is 'normalized’.

This webinar will discuss alcohol use disorder (AUD) among women of childbearing age with HIV. Participants will gain actionable insights into evidence-based care, treatments, and minimizing barriers to medications for alcohol use disorder (MAUD). This session will emphasize integrating AUD and HIV care to improve outcomes for patients and promote better health outcomes.

This case-based discussion will explore strategies to build trust with patients and reduce the impacts of alcohol use through real-world scenarios. Attendees will gain skills to foster ongoing engagement with patients wherever they may be within the stages of change, while providing essential care to treat alcohol use disorder.

Alcohol use disorder (AUD) remains a major public health concern and is disproportionately represented in acute care settings. Hospitals present an opportunity to both recognize and treat AUD amongst these patients. Join Dr. Joji Suzuki as he leads this one hour webinar that delves into this important topic.

Major depressive disorder is the most common co-occurring psychiatric disorder among people with alcohol use disorder (AUD). Comorbid substance use disorder and depression or bipolar disorder are associated with a higher risk of suicide attempts or death from suicide. This one hour webinar is led by Rebecca Payne, MD and will look at the assessment and treatment options.

This case-based discussion will explore barriers that limit access to medications for alcohol use disorder (MAUD), with a focus on populations with unique clinical needs. It will discuss evidence-based and community-informed strategies for addressing these barriers and learn how to apply practical interventions at the organizational and provider level.

Co-occurring psychiatric conditions are common in patients with alcohol use disorder (AUD). In this webinar, Vanessa Loukas, MSN, FNP-C, CARN-AP will discuss some of these conditions, how they affect and are affected by AUD and treatments that can help.

In this case-based discussion led by Dr. Marc Manseau, participants will explore the general principles of integrated treatment strategies for addressing co-occurring alcohol use disorder (AUD) and tobacco use disorder (TUD). In addition to exploring case-style examples, attendees will gain a better understanding on how medications can be a part of treatment.

Have questions about treating alcohol use disorder? The PCSS-MAUD Office Hour series provides space for open discussion for healthcare professionals to ask questions and receive support from experts in the field. Dr. Andrea Jodat will be the expert for the September session. Can’t make the whole session? Feel free to come and go as you please.